Coriell Institute for Medical Research
Coriell Institute of Medical Research
  • Request a Quote
  • Donate
  • Login
  • View Cart
Sample Catalog | Custom Services | Core Facilities | Genomic Data Search
  • Biobank
    • NIGMS
    • NINDS
    • NIA
    • NHGRI
    • NEI
    • Allen Cell Collection
    • Rett Syndrome iPSC Collection
    • Autism Research Resource
    • HD Community Biorepository
    • CDC Cell and DNA
    • J. Craig Venter Institute
    • Orphan Disease Center Collection
    • All Biobanks
  • Research
    • Overview
    • Meet Our Scientists
      • Our Faculty
      • Our Scientific Staff
    • Camden Cancer Research Center
    • Epigenetic Therapies SPORE
    • Core Facilities
    • Epigenomics
    • Camden Opioid Research Initiative (CORI)
    • The Issa & Jelinek Lab
    • The Jian Huang Lab
    • The Luke Chen Lab
      • The Lab
      • The Team
      • Publications
    • The Scheinfeldt Lab
    • The Shumei Song Lab
    • The Nora Engel Lab
      • The Lab
      • The Team
      • Publications
    • Publications
  • Services
    • Overview
    • Biobanking Services
      • Core Services
      • Project Management
      • Research Support Services
      • Sample Cataloging
      • Sample Collection Kits
      • Sample Data Management
      • Sample Distribution
      • Sample Management
      • Sample Procurement
      • Sample Storage
    • Bioinformatics and Biostatistics Services
    • Cellular and Molecular Services
      • Biomarker Research Solutions
      • Cell Culture
      • Nucleic Acid Isolation and Quality Control
    • Clinical Trial Support
      • Overview
      • Sample Collection
      • Data Management
      • Sample Processing and QC
      • Storage and Distribution
      • Biomarker Services
      • Data Analaysis
    • Core Facilties
      • Overview
      • Animal and Xenograft
      • Bioinformatics and Biostatistics
      • Cell Imaging
      • CRISPR Gene Engineering
      • Flow Cytometry and Cell Sorting
      • Genomics and Epigenomics
      • iPSC - Induced Pluripotent Stem Cells
      • Organoids
    • Coriell Marketplace
    • Genomic, Epigenomic and Multiomics Services
    • Stem Cells and iPSC Services
      • Core Services
      • Reprogramming
      • Characterization and Quality Control
      • Differentiated Cell Lines
      • iPSC-Derived Organoids
      • iPSC Expansion
      • iPSC Gene Editing
  • Ordering
    • Stem Cells
    • Cell Lines
    • DNA and RNA
    • Featured Products
      • FFPE
      • HMW DNA
    • Genomic Data Search
    • Search by Catalog ID
    • Help
      • Create Account
      • Order Online
      • Ordering FAQ
      • FAQs/Culture Instructions
      • Reference Materials
        • Biobanks
        • NIGMS Repository
        • NHGRI Repository
        • NINDS Repository
        • NIA Repository
        • NIST
        • GeT-RM
      • Secondary Distribution Policies
      • MTA Assurance Form
      • Shipment Policy
      • Contact Customer Service
  • About Us
    • Our History
    • Meet Our Team
    • Meet Our Board
    • Education
      • Science Fair
      • Summer Experience
      • Outreach
      • Research Program Internship
    • Press Room
      • Press Releases
      • Coriell Blog
      • Annual Report
    • Careers
      • Working at Coriell
    • Giving
      • Donate
      • Giving FAQ
    • Contact Us
    • Legal Notice
  • Login View Cart
search submit
GM25340 LCL from B-Lymphocyte

Description:

CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG
N-GLYCANASE 1; NGLY1

Affected:

Yes

Sex:

Male

Age:

6 YR (At Sampling)

  • Overview
  • Characterizations
  • Phenotypic Data
  • Publications
  • External Links
  • Culture Protocols

Overview

back to top
Repository NIGMS Human Genetic Cell Repository
Subcollection Heritable Diseases
PIGI Consented Sample
Biopsy Source Peripheral vein
Cell Type B-Lymphocyte
Tissue Type Blood
Transformant Epstein-Barr Virus
Sample Source LCL from B-Lymphocyte
Race White
Ethnicity Hispanic/Latino
Ethnicity Puerto Rican/German/Polish
Country of Origin USA
Family Member 1
Family History N
Relation to Proband proband
Species Homo sapiens
Common Name Human
Remarks Clinically affected; onset of symptoms at birth; diagnosed with N-glycanase deficiency at 4 years of age; symptoms at birth: neonatal jaundice, global developmental delay, hypotonia, involuntary movements (athetosis involving the trunk and extremities and constant lip smacking and pursing), intractable multifocal epilepsy (consisting of myoclonic seizures, drop attacks, and staring or tonic episodes), abnormal liver function; At 15 months of age subject showed regression of motor development; At 4 years of age subject was noted to have cortical vision impairment, congenital alacrima (absence of tears), corneal ulcerations with scarring; At 5 years of age subject continues to have movement disorder, able to sit up, able to reach for objects and transfer them from hand to hand, never developed speech, abnormal EEG, decreased deep tendon reflexes, seizures, chalazions, elevated liver transaminases, elevated AFP, liver fibrosis, liver storage or vacuolization, constipation, peripheral neuropathy, small hands and feet; brain MRI at 8 months was normal but brain MRI at 15 months detected prominent perivascular spaces with surrounding gliosis in periatrial white matter and mildly delayed myelination; liver biopsy showed inflammatory changes with an amorphous substance in the cytoplasm; abnormal urine oligosaccharides with keratan sulfate, heparan sulfate, and chondroitin sulfate; testing for congenital disorders of glycosylation was normal by transferrin isoelectric focusing and N-glycan analysis; biochemical testing by Western blot showed no detectable NGLY1; molecular genetic testing by whole exome sequencing (WES) revealed compound heterozygous mutations in the NGLY1 gene: maternally inherited c.1891delC (p.Q631fs - frameshift mutation in exon 12) and paternally inherited c.1201A>T (p.R401X - nonsense mutation in exon 8); treatment and management includes: medications, physical therapy, occupational therapy, and speech language therapy; assistive devices: wheelchair, braces, orthotics, communication/learning device; mother (GM25341); father (GM25342) . [Subject is referenced as Trio 2 in publication by Needs et al 2012 – PMID 22581936, and Patient 1 in publication by Enns et al. 2014 - PMID 24651605]

Characterizations

back to top
IDENTIFICATION OF SPECIES OF ORIGIN Species of Origin Confirmed by LINE assay
 
Gene NGLY1
Chromosomal Location 3p24.2
Allelic Variant 1 610661.0001; CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG
Identified Mutation c.1891delC
 
Gene NGLY1
Chromosomal Location 3p24.2
Allelic Variant 1 610661.0002; CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG
Identified Mutation ARG401TER; For discussion of the arg401-to-ter (R401X) mutation in the NGLY1 gene that was found in compound heterozygous state in a patient with congenital disorder of deglycosylation (CDDG; 615273) by Need et al. (2012), see 610661.0001.

Phenotypic Data

back to top
Remarks Clinically affected; onset of symptoms at birth; diagnosed with N-glycanase deficiency at 4 years of age; symptoms at birth: neonatal jaundice, global developmental delay, hypotonia, involuntary movements (athetosis involving the trunk and extremities and constant lip smacking and pursing), intractable multifocal epilepsy (consisting of myoclonic seizures, drop attacks, and staring or tonic episodes), abnormal liver function; At 15 months of age subject showed regression of motor development; At 4 years of age subject was noted to have cortical vision impairment, congenital alacrima (absence of tears), corneal ulcerations with scarring; At 5 years of age subject continues to have movement disorder, able to sit up, able to reach for objects and transfer them from hand to hand, never developed speech, abnormal EEG, decreased deep tendon reflexes, seizures, chalazions, elevated liver transaminases, elevated AFP, liver fibrosis, liver storage or vacuolization, constipation, peripheral neuropathy, small hands and feet; brain MRI at 8 months was normal but brain MRI at 15 months detected prominent perivascular spaces with surrounding gliosis in periatrial white matter and mildly delayed myelination; liver biopsy showed inflammatory changes with an amorphous substance in the cytoplasm; abnormal urine oligosaccharides with keratan sulfate, heparan sulfate, and chondroitin sulfate; testing for congenital disorders of glycosylation was normal by transferrin isoelectric focusing and N-glycan analysis; biochemical testing by Western blot showed no detectable NGLY1; molecular genetic testing by whole exome sequencing (WES) revealed compound heterozygous mutations in the NGLY1 gene: maternally inherited c.1891delC (p.Q631fs - frameshift mutation in exon 12) and paternally inherited c.1201A>T (p.R401X - nonsense mutation in exon 8); treatment and management includes: medications, physical therapy, occupational therapy, and speech language therapy; assistive devices: wheelchair, braces, orthotics, communication/learning device; mother (GM25341); father (GM25342) . [Subject is referenced as Trio 2 in publication by Needs et al 2012 – PMID 22581936, and Patient 1 in publication by Enns et al. 2014 - PMID 24651605]

Publications

back to top
Sarute N, Ross SR, CACNA1S haploinsufficiency confers resistance to New World arenavirus infection Proceedings of the National Academy of Sciences of the United States of America117:19497-19506 2020
PubMed ID: 32719120
 
Enns GM, Shashi V, Bainbridge M, Gambello MJ, Zahir FR, Bast T, Crimian R, Schoch K, Platt J, Cox R, Bernstein JA, Scavina M, Walter RS, Bibb A, Jones M, Hegde M, Graham BH, Need AC, Oviedo A, Schaaf CP, Boyle S, Butte AJ, Chen R, Clark MJ, Haraksingh R, Cowan TM, He P, Langlois S, Zoghbi HY, Snyder M, Gibbs RA, Freeze HH, Goldstein DB, Mutations in NGLY1 cause an inherited disorder of the endoplasmic reticulum-associated degradation pathway Genetics in medicine : official journal of the American College of Medical Genetics16:751-8 2013
PubMed ID: 24651605
 
Need AC, Shashi V, Hitomi Y, Schoch K, Shianna KV, McDonald MT, Meisler MH, Goldstein DB, Clinical application of exome sequencing in undiagnosed genetic conditions Journal of medical genetics49:353-61 2012
PubMed ID: 22581936

External Links

back to top
Gene Cards NGLY1
NCBI GTR 610661 N-GLYCANASE 1; NGLY1
615273 CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG
OMIM 610661 N-GLYCANASE 1; NGLY1
615273 CONGENITAL DISORDER OF DEGLYCOSYLATION; CDDG

Culture Protocols

back to top
Split Ratio 1:3
Temperature 37 C
Percent CO2 5%
Percent O2 AMBIENT
Medium Roswell Park Memorial Institute Medium 1640 with 2mM L-glutamine or equivalent
Serum 15% fetal bovine serum Not Inactivated
Substrate None specified
Subcultivation Method dilution - add fresh medium
Supplement -
Pricing
International/Commercial/For-profit:
$373.00USD
U.S. Academic/Non-profit/Government:
$216.00USD
Add to Cart
How to Order
  • Ordering Instructions
  • MTA / Assurance Form
  • Statement of Research Intent Form
Related Products
Same Family
  • 3199
Miscellaneous
  • DNA on Demand
  • Custom Services

Our mission is to prevent and cure disease through biomedical research.

CONTACT US

CUSTOMER SERVICE
customerservice@coriell.org (800) 752-3805 • (856) 757-4848
Subscribe to our newsletter here

Coriell Institute for Medical Research
403 Haddon Avenue Camden, NJ 08103, USA (856) 966-7377

Ⓒ 2025 Coriell Institute. All rights reserved.

  • Facebook
  • Linkedin
  • Youtube